The oncologist and former University of California, San Francisco, professor has long been critical of COVID-19 mandates and ...

Twenty attorneys general allege that the recent workforce reduction at the Department of Health and Human Services is ...

In light of President Donald Trump’s impending pharma tariffs, several big companies have made massive manufacturing ...

Biopharma venture capital fundraising declined from $8.1 billion in the first quarter of 2024 to $6.5 billion in the first ...

A new executive order from President Donald Trump aims to cut down the 5-to-10-year timeline to build new facilities while ...

Vertex has recorded some 25,000 prescriptions for Journavx since its January approval and is in the process of getting big ...